Health

  • April 17, 2026

    Fed. Circ. Reverses $18M Penile Implant Trade Secret Win

    In a unanimous precedential decision, the Federal Circuit on Friday largely reversed a California jury's $18.3 million trade secret verdict over a penile implant, holding that the asserted secrets were already publicly disclosed or generally known and therefore not protectable.

  • April 16, 2026

    2nd Circ. Says Animal Groups Can't Challenge Swine Rule

    The Second Circuit on Thursday held that a trio of animal welfare groups don't have the standing to fight the U.S. Department of Agriculture's revised practices for inspecting pigs at slaughterhouses, ruling that none of the groups have shown they are likely to be harmed by the rule.

  • April 16, 2026

    Trump Taps Ret. Rear Admiral Schwartz As New CDC Chief

    President Donald Trump on Thursday nominated Dr. Erica Schwartz, a retired rear admiral who served in the U.S. Coast Guard and as deputy surgeon general in the first Trump administration, to be the Centers for Disease Control and Prevention's next director.

  • April 16, 2026

    Tenn. Judge Keeps Filipino Nurses' Trafficking Suit Alive

    A Tennessee federal judge denied a bid by a long-term care provider and a foreign nursing recruiter to dismiss a proposed class action brought by Filipino nurses who alleged they were forced to sign abusive contracts that amount to "indentured servitude."

  • April 16, 2026

    HHS Defends ACA Overhaul Against Cities' Challenge

    The Health and Human Services Department is defending sweeping changes to the Affordable Care Act marketplace against attacks from three cities, asking a Maryland federal judge to grant summary judgment and allow the agency to shorten open enrollment, institute tighter income checks and charge a reenrollment verification premium.

  • April 16, 2026

    Fed. Circ. Says Judge Wrongly Axed Teva's $177M Eli Lilly Win

    The Federal Circuit ruled Thursday that a Massachusetts federal judge was wrong to overturn a $177 million jury verdict that Teva won against Eli Lilly & Co. on headache drug patents, finding that contrary to the judge's finding, the patents are not invalid.

  • April 16, 2026

    Feds Can't Stay Trans Healthcare Orders During Appeal

    The Trump administration won't be able to enforce two executive orders that ban federal funding for gender-affirming care for patients under the age of 19 while the federal government appeals a nationwide injunction blocking the orders, the Fourth Circuit ruled Thursday. 

  • April 16, 2026

    Del. Rejects Fiduciary Claim Over Competing Opioid Clinic

    The Delaware Chancery Court on Thursday largely rejected a healthcare company's claims that a former executive unlawfully competed against it by launching a nearby opioid treatment clinic, finding only a narrow breach of fiduciary duty and awarding just over $1,600 in damages.

  • April 16, 2026

    DOL Benefits Chief Pressed On Labor Secretary's Conduct

    The head of the U.S. Department of Labor's employee benefits arm faced tough questions from House Democrats at an oversight hearing Thursday, fielding questions about the labor secretary's on-the-job conduct as well as the DOL's take on mental health parity enforcement. 

  • April 16, 2026

    Texas Patients Say Defective Sutures Caused Disfigurement

    Four patients who received cosmetic facial procedures told a Texas federal court that sutures used during their procedures caused painful facial bacterial abscesses and permanent scarring, claiming the sutures never received FDA approval.

  • April 16, 2026

    Armed Services Board Says DHA Agreement Wasn't A Contract

    The Armed Services Board of Contract Appeals dismissed an appeal from a Defense Health Agency supply vendor whose agreement was terminated years before its end date, finding it did not amount to a contract.

  • April 16, 2026

    Katten Partner Rejoins Epstein Becker In DC For 3rd Time

    Epstein Becker Green LLP has rehired, for the third time, a healthcare transactional attorney who focuses his practice on guiding hospital systems, private equity-backed entities and professional practices on transactional matters and regulatory compliance.

  • April 15, 2026

    Larry King's Estate Says Supplement Co. Still Using His Name

    Larry King's estate sued operators of a prostate health supplement company in California state court Wednesday, alleging they continued using his name and likeness to advertise their product even after striking a legal settlement agreeing to stop.

  • April 15, 2026

    Consumer Cases Drive Class Action Spike, Report Says

    Federal class action filings spiked in 2025 after nearly a decade of relative stability, fueled by a surge in consumer protection lawsuits tied to data breaches, digital commerce and online accessibility claims, according to a new report from Lex Machina.

  • April 15, 2026

    'A Bunch Of Games': MDL Judge Irked By Meta, AGs Sparring

    A California federal judge appeared skeptical Wednesday of Meta Platforms Inc.'s request for a summary judgment win over claims by state attorneys general in multidistrict social media addiction litigation, saying repeatedly that many disputes should be resolved at trial and panning some arguments by both sides as "a bunch of games."

  • April 15, 2026

    Hims & Hers Providers Can't Duck Suit Over Student's Suicide

    Medical providers for telehealth company Hims & Hers can't escape a wrongful death lawsuit from the family of a Washington State University freshman who died by suicide in 2023, according to a Washington state judge's order denying summary judgment motions from five individual defendants.

  • April 15, 2026

    Amneal Trims But Can't Nix AGs' Drug Price-Fixing Suit

    There is enough evidence from which a jury could conclude that Amneal Pharmaceuticals participated in a conspiracy to fix the price of an epilepsy medication, but not enough to show it participated in the overarching antitrust conspiracy alleged by dozens of state attorneys general, a Connecticut federal judge ruled Wednesday.

  • April 15, 2026

    Drugmaker Aquestive's Brass Sued Over FDA Setback

    Executives and directors of pharmaceutical company Aquestive Therapeutics Inc. were hit with a shareholder's derivative suit Wednesday accusing them of ignoring deficiencies in a research study for Aquestive's allergic reaction treatment, which eventually prompted the U.S. Food and Drug Administration to reject the company's new drug application.

  • April 15, 2026

    'Law, Not Liturgy'?: 9th Circ. Split Over Faith Bias COVID Suit

    Eight judges dissented Wednesday from the denial of an en banc Ninth Circuit rehearing of a panel's decision not to revive a Christian hospital worker's religious bias lawsuit alleging she was fired for refusing COVID-19 nasal testing, with one dissenting judge saying "courts are unwelcome guests" when deciding the veracity of an individual's belief.

  • April 15, 2026

    Judge Won't Move 'Maya' Case For Retrial

    A Florida judge on Wednesday denied a hospital's request to move a retrial of Netflix documentary subject Maya Kowalski's claims against the hospital from Sarasota to St. Petersburg, citing the difficulty and expense of moving the 8-year-old case to a new circuit and judge.

  • April 15, 2026

    Aluminum Co. Settles Trans Worker's Suit Over Health Plan

    A subsidiary of Kaiser Aluminum has agreed to resolve a lawsuit claiming it discriminated against transgender employees by excluding coverage for medical treatments related to gender-affirming care from its health plan, according to a filing in Washington federal court.

  • April 15, 2026

    What To Know About DOL's Benefits Enforcement Update

    The U.S. Department of Labor's employee benefits arm recently issued updated enforcement guidance that highlighted the agency's goal of shifting to focus more on breaches of the fiduciary duty of loyalty under federal benefits law. Here are three things experts said stood out about the DOL's update.

  • April 15, 2026

    Women's Health Co. Accused Of Unauthorized Data Sharing

    A private women's healthcare system is facing a proposed class action in Pennsylvania federal court that alleges it allowed third parties to use sensitive patient information without consent or notice.

  • April 15, 2026

    Fertility Biz Progyny Hit With TM Suit In Pennsylvania

    Fertility benefit management company Progyny Inc.'s expansion into pregnancy and postpartum care while using the "Progyny" trademark will create confusion in the marketplace by overlapping with similar but differently spelled marks, a new lawsuit from ProgenyHealth LLC claims.

  • April 15, 2026

    Fed. Circ. Won't Make It Harder To Undo CICA Stay Overrides

    The Federal Circuit declined to impose a heightened standard of review when judges are considering a federal agency's decision to override an automatic pause on contract performance during a bid protest at the U.S. Government Accountability Office.

Expert Analysis

  • 4 Trends Shaping Drug And Medical Device Law For 2026

    Author Photo

    2025 saw some significant legal developments with potential impact for drug and device manufacturers, ranging from growing skepticism in science and regulatory entities to new regulation of artificial intelligence, say attorneys at Faegre Drinker.

  • Key Trends In Healthcare Antitrust In 2025

    Author Photo

    The healthcare industry braced for significant antitrust enforcement shifts last year driven by a change in administration, and understanding the implications of these trends is critical for healthcare organizations' risk management and strategic decision-making in the year ahead, say attorneys at Michael Best.

  • The 5 Most Important Bid Protest Decisions Of 2025

    Author Photo

    In a shifting bid protest landscape, five decisions in 2025 from the Federal Circuit, the U.S. Court of Federal Claims and the U.S. Government Accountability Office that addressed bedrock questions about jurisdictional reach and the breadth of agency discretion are likely to have a lasting impact, say attorneys at Bradley Arant.

  • Food Industry Braces For MAHA And Other Challenges In 2026

    Author Photo

    After the Make America Healthy Again movement kept the U.S. Food and Drug Administration under pressure in 2025, actions in the food safety space are likely to continue this year, including updated Supplemental Nutrition Assistance Program dietary guidelines and processed food definitions, say attorneys at Wiley.

  • Preparing For Congressional Investigations In A Midterm Year

    Author Photo

    2026 will be a consequential year for congressional oversight as the upcoming midterm elections may yield bolder investigations and more aggressive state attorneys general coalitions, so companies should consider adopting risk management measures to get ahead of potential changes, say attorneys at Morgan Lewis.

  • A Meaningful Shift In FDA's Biosimilarity Analysis

    Author Photo

    The U.S. Food and Drug Administration's potential pivot away from routinely requiring comparative efficacy studies for interchangeable biosimilar applications would not lower regulatory standards, but instead allow applicants to allocate resources toward establishing more probative evidence, says Theodore Thompson at Stinson.

  • Employment Immigration Trends And Challenges For 2026

    Author Photo

    U.S. companies competing for global talent should brace for a turbulent 2026, with greater compliance burdens, higher costs and the probability of workforce disruptions at every stage of the immigration process, from visa petitions to work authorization renewals, say attorneys at Duane Morris.

  • Top 5 Antitrust Issues For In-House Counsel To Watch In 2026

    Author Photo

    With Trump administration enforcement policy having largely taken shape last year, antitrust issues that in-house counsel should have on the radar range from scrutiny of technology-assisted pricing to the return of merger remedies, say attorneys at Squire Patton.

  • 4 Developments That Defined The 2025 Ethics Landscape

    Author Photo

    The legal profession spent 2025 at the edge of its ethical comfort zone as courts, firms and regulators confronted how fast-moving technologies and new business models collide with long-standing professional duties, signaling that the profession is entering a period of sustained disruption that will continue into 2026, says Hilary Gerzhoy at HWG Law.

  • Navigating AI In The Legal Industry

    Author Photo

    As artificial intelligence becomes an increasingly integral part of legal practice, Law360 guest commentary this year examined evolving ethical obligations, how the plaintiffs bar is using AI to level the playing field against corporate defense teams, and the attendant risks of adoption.

  • How Fractional GCs Can Manage Risks Of Engagement

    Author Photo

    As more organizations eliminate their in-house legal departments in favor of outsourcing legal work, fractional general counsel roles offer practitioners an engaging and flexible way to practice at a high level, but they can also present legal, ethical and operational risks that must be proactively managed, say attorneys at Boies Schiller.

  • Health, Legal Employers Face Unique Online Speech Hurdles

    Author Photo

    Employers in the legal and healthcare industries must consider distinctive ethical obligations and professional requirements when disciplining employees for social media posts, while anticipating an area of the law in flux as courts seek to balance speech rights and the workplace function, say attorneys at FordHarrison.

  • Reviewing 2025's Most Pertinent Wiretap Developments

    Author Photo

    2025 was a remarkable year in the world of web tracking wiretapping litigation, not only for the increased caseload but also because of numerous developing theories of liability, with disputes expected to continue unabated in 2026, say attorneys at Squire Patton.

  • 2025 Legal Milestones That Will Shape Psychedelics Sector

    Author Photo

    As 2025 draws to a close, psychedelic drug development stands at an inflection point, experiencing unprecedented momentum through recent sweeping regulatory changes and landmark clinical milestones, amid rapidly evolving regulatory expectations, say Odette Hauke at Odette Alina LLC and Kimberly Chew at Husch Blackwell.

  • Series

    Nature Photography Makes Me A Better Lawyer

    Author Photo

    Nature photography reminds me to focus on what is in front of me and to slow down to achieve success, and, in embracing the value of viewing situations through different lenses, offers skills transferable to the practice of law, says Brian Willett at Saul Ewing.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Health archive.